nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0549	0.215	CbGbCtD
Boceprevir—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0371	0.145	CbGbCtD
Boceprevir—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0354	0.139	CbGbCtD
Boceprevir—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0316	0.124	CbGbCtD
Boceprevir—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0309	0.121	CbGbCtD
Boceprevir—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0292	0.114	CbGbCtD
Boceprevir—CTSK—leg—chronic obstructive pulmonary disease	0.0211	0.141	CbGeAlD
Boceprevir—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0185	0.0726	CbGbCtD
Boceprevir—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0175	0.0685	CbGbCtD
Boceprevir—CMA1—respiratory system—chronic obstructive pulmonary disease	0.00813	0.0544	CbGeAlD
Boceprevir—CMA1—connective tissue—chronic obstructive pulmonary disease	0.00715	0.0479	CbGeAlD
Boceprevir—CTSV—bronchus—chronic obstructive pulmonary disease	0.007	0.0469	CbGeAlD
Boceprevir—CTSL—respiratory system—chronic obstructive pulmonary disease	0.00695	0.0465	CbGeAlD
Boceprevir—CMA1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00654	0.0438	CbGeAlD
Boceprevir—CTSV—trachea—chronic obstructive pulmonary disease	0.00629	0.0421	CbGeAlD
Boceprevir—CTSL—connective tissue—chronic obstructive pulmonary disease	0.00612	0.041	CbGeAlD
Boceprevir—CTSL—bronchus—chronic obstructive pulmonary disease	0.00572	0.0383	CbGeAlD
Boceprevir—CTSL—smooth muscle tissue—chronic obstructive pulmonary disease	0.0056	0.0375	CbGeAlD
Boceprevir—CTSK—respiratory system—chronic obstructive pulmonary disease	0.00524	0.0351	CbGeAlD
Boceprevir—CTSL—trachea—chronic obstructive pulmonary disease	0.00514	0.0344	CbGeAlD
Boceprevir—CTSK—connective tissue—chronic obstructive pulmonary disease	0.00461	0.0309	CbGeAlD
Boceprevir—CTSS—respiratory system—chronic obstructive pulmonary disease	0.00459	0.0307	CbGeAlD
Boceprevir—CTSV—lung—chronic obstructive pulmonary disease	0.00452	0.0303	CbGeAlD
Boceprevir—CMA1—lung—chronic obstructive pulmonary disease	0.00431	0.0289	CbGeAlD
Boceprevir—CTSK—bronchus—chronic obstructive pulmonary disease	0.00431	0.0289	CbGeAlD
Boceprevir—CTSK—smooth muscle tissue—chronic obstructive pulmonary disease	0.00422	0.0282	CbGeAlD
Boceprevir—CTSS—connective tissue—chronic obstructive pulmonary disease	0.00404	0.027	CbGeAlD
Boceprevir—CTSK—trachea—chronic obstructive pulmonary disease	0.00387	0.0259	CbGeAlD
Boceprevir—Telaprevir—ALB—chronic obstructive pulmonary disease	0.00386	1	CrCbGaD
Boceprevir—CTSS—bronchus—chronic obstructive pulmonary disease	0.00378	0.0253	CbGeAlD
Boceprevir—CTSS—smooth muscle tissue—chronic obstructive pulmonary disease	0.00369	0.0247	CbGeAlD
Boceprevir—CTSL—lung—chronic obstructive pulmonary disease	0.00369	0.0247	CbGeAlD
Boceprevir—CTSS—trachea—chronic obstructive pulmonary disease	0.00339	0.0227	CbGeAlD
Boceprevir—CTSK—lung—chronic obstructive pulmonary disease	0.00278	0.0186	CbGeAlD
Boceprevir—CTSS—lung—chronic obstructive pulmonary disease	0.00244	0.0163	CbGeAlD
Boceprevir—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.00152	0.0102	CbGeAlD
Boceprevir—CTSL—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00103	0.253	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00103	0.253	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.247	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.247	CbGdCrCtD
Boceprevir—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000809	0.00542	CbGeAlD
Boceprevir—CYP3A5—lung—chronic obstructive pulmonary disease	0.000809	0.00542	CbGeAlD
Boceprevir—ABCB1—trachea—chronic obstructive pulmonary disease	0.000598	0.00401	CbGeAlD
Boceprevir—ABCB1—lung—chronic obstructive pulmonary disease	0.00043	0.00288	CbGeAlD
Boceprevir—CTSV—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.000396	0.00149	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.000396	0.00149	CbGpPWpGaD
Boceprevir—CTSS—Collagen formation—MMP9—chronic obstructive pulmonary disease	0.000393	0.00147	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP9—chronic obstructive pulmonary disease	0.000375	0.00141	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.000368	0.00138	CbGpPWpGaD
Boceprevir—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000361	0.00135	CbGpPWpGaD
Boceprevir—CTSK—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000355	0.00133	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—MMP9—chronic obstructive pulmonary disease	0.000354	0.00133	CbGpPWpGaD
Boceprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000352	0.00132	CbGpPWpGaD
Boceprevir—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000346	0.0013	CbGpPWpGaD
Boceprevir—CTSK—Immune System—LY96—chronic obstructive pulmonary disease	0.000346	0.0013	CbGpPWpGaD
Boceprevir—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000332	0.00124	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.000328	0.00123	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000325	0.00122	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000325	0.00122	CbGpPWpGaD
Boceprevir—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000321	0.000998	CcSEcCtD
Boceprevir—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.000998	CcSEcCtD
Boceprevir—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00032	0.000996	CcSEcCtD
Boceprevir—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000319	0.000995	CcSEcCtD
Boceprevir—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000319	0.0012	CbGpPWpGaD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000319	0.000993	CcSEcCtD
Boceprevir—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000318	0.000991	CcSEcCtD
Boceprevir—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.000988	CcSEcCtD
Boceprevir—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.000988	CcSEcCtD
Boceprevir—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.000977	CcSEcCtD
Boceprevir—Infection—Formoterol—chronic obstructive pulmonary disease	0.000312	0.000972	CcSEcCtD
Boceprevir—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.000972	CcSEcCtD
Boceprevir—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.000964	CcSEcCtD
Boceprevir—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.000964	CcSEcCtD
Boceprevir—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.000964	CcSEcCtD
Boceprevir—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000309	0.000963	CcSEcCtD
Boceprevir—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.00096	CcSEcCtD
Boceprevir—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.000959	CcSEcCtD
Boceprevir—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000308	0.000959	CcSEcCtD
Boceprevir—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000308	0.000958	CcSEcCtD
Boceprevir—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.000955	CcSEcCtD
Boceprevir—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000307	0.000955	CcSEcCtD
Boceprevir—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.000952	CcSEcCtD
Boceprevir—Infection—Montelukast—chronic obstructive pulmonary disease	0.000306	0.000952	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000306	0.00115	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000306	0.00115	CbGpPWpGaD
Boceprevir—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000305	0.000951	CcSEcCtD
Boceprevir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.00095	CcSEcCtD
Boceprevir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000305	0.00095	CcSEcCtD
Boceprevir—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000304	0.000947	CcSEcCtD
Boceprevir—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000303	0.00114	CbGpPWpGaD
Boceprevir—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000942	CcSEcCtD
Boceprevir—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000302	0.00094	CcSEcCtD
Boceprevir—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000301	0.000938	CcSEcCtD
Boceprevir—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000301	0.000938	CcSEcCtD
Boceprevir—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000301	0.000936	CcSEcCtD
Boceprevir—CTSL—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000301	0.00113	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000301	0.00113	CbGpPWpGaD
Boceprevir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000299	0.000931	CcSEcCtD
Boceprevir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000296	0.00111	CbGpPWpGaD
Boceprevir—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.000918	CcSEcCtD
Boceprevir—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000294	0.000914	CcSEcCtD
Boceprevir—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.000914	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.000293	0.0011	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.000293	0.0011	CbGpPWpGaD
Boceprevir—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000293	0.000913	CcSEcCtD
Boceprevir—CTSS—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000292	0.0011	CbGpPWpGaD
Boceprevir—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000292	0.0011	CbGpPWpGaD
Boceprevir—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000292	0.000909	CcSEcCtD
Boceprevir—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.000909	CcSEcCtD
Boceprevir—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.000906	CcSEcCtD
Boceprevir—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.000901	CcSEcCtD
Boceprevir—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000289	0.000901	CcSEcCtD
Boceprevir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.000897	CcSEcCtD
Boceprevir—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000288	0.00108	CbGpPWpGaD
Boceprevir—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000287	0.000893	CcSEcCtD
Boceprevir—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.000893	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000286	0.000891	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.000891	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	0.000286	0.00107	CbGpPWpGaD
Boceprevir—CTSS—Immune System—LY96—chronic obstructive pulmonary disease	0.000285	0.00107	CbGpPWpGaD
Boceprevir—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.000885	CcSEcCtD
Boceprevir—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000284	0.000885	CcSEcCtD
Boceprevir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000282	0.000879	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00028	0.000873	CcSEcCtD
Boceprevir—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00028	0.000872	CcSEcCtD
Boceprevir—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.000872	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.00028	0.00105	CbGpPWpGaD
Boceprevir—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000278	0.000867	CcSEcCtD
Boceprevir—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.000863	CcSEcCtD
Boceprevir—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000277	0.00104	CbGpPWpGaD
Boceprevir—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.000861	CcSEcCtD
Boceprevir—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000277	0.000861	CcSEcCtD
Boceprevir—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00086	CcSEcCtD
Boceprevir—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000275	0.000858	CcSEcCtD
Boceprevir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000273	0.00085	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000271	0.000845	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.000845	CcSEcCtD
Boceprevir—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000271	0.000843	CcSEcCtD
Boceprevir—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000271	0.000843	CcSEcCtD
Boceprevir—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.000843	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.000842	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.00027	0.00101	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000269	0.00101	CbGpPWpGaD
Boceprevir—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.000837	CcSEcCtD
Boceprevir—Pain—Formoterol—chronic obstructive pulmonary disease	0.000269	0.000837	CcSEcCtD
Boceprevir—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.000837	CcSEcCtD
Boceprevir—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000269	0.000837	CcSEcCtD
Boceprevir—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.000835	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000268	0.00101	CbGpPWpGaD
Boceprevir—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000834	CcSEcCtD
Boceprevir—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.000829	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000266	0.000827	CcSEcCtD
Boceprevir—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000265	0.000826	CcSEcCtD
Boceprevir—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.000823	CcSEcCtD
Boceprevir—Pain—Montelukast—chronic obstructive pulmonary disease	0.000263	0.000819	CcSEcCtD
Boceprevir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000262	0.000817	CcSEcCtD
Boceprevir—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000262	0.000984	CbGpPWpGaD
Boceprevir—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000262	0.000814	CcSEcCtD
Boceprevir—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.000813	CcSEcCtD
Boceprevir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00081	CcSEcCtD
Boceprevir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00081	CcSEcCtD
Boceprevir—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.000807	CcSEcCtD
Boceprevir—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.000806	CcSEcCtD
Boceprevir—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000259	0.000806	CcSEcCtD
Boceprevir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.000805	CcSEcCtD
Boceprevir—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.000803	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000258	0.000967	CbGpPWpGaD
Boceprevir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000257	0.000802	CcSEcCtD
Boceprevir—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000257	0.0008	CcSEcCtD
Boceprevir—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.0008	CcSEcCtD
Boceprevir—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000799	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.000797	CcSEcCtD
Boceprevir—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.000796	CcSEcCtD
Boceprevir—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00079	CcSEcCtD
Boceprevir—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00079	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000253	0.00095	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000252	0.000784	CcSEcCtD
Boceprevir—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.000777	CcSEcCtD
Boceprevir—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00025	0.000777	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000249	0.000935	CbGpPWpGaD
Boceprevir—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.000773	CcSEcCtD
Boceprevir—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000248	0.000773	CcSEcCtD
Boceprevir—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.000773	CcSEcCtD
Boceprevir—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000248	0.000773	CcSEcCtD
Boceprevir—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000771	CcSEcCtD
Boceprevir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.000771	CcSEcCtD
Boceprevir—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000765	CcSEcCtD
Boceprevir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.000764	CcSEcCtD
Boceprevir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.000764	CcSEcCtD
Boceprevir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000245	0.000763	CcSEcCtD
Boceprevir—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000244	0.000761	CcSEcCtD
Boceprevir—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.000761	CcSEcCtD
Boceprevir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000244	0.000759	CcSEcCtD
Boceprevir—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000243	0.000757	CcSEcCtD
Boceprevir—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000243	0.000757	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.000243	0.000913	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.000755	CcSEcCtD
Boceprevir—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000241	0.000904	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000241	0.000904	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00024	0.000901	CbGpPWpGaD
Boceprevir—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00024	0.000748	CcSEcCtD
Boceprevir—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000742	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.000237	0.000888	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.000237	0.000888	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000236	0.000886	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000236	0.000886	CbGpPWpGaD
Boceprevir—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.000734	CcSEcCtD
Boceprevir—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00073	CcSEcCtD
Boceprevir—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00073	CcSEcCtD
Boceprevir—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000232	0.00087	CbGpPWpGaD
Boceprevir—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000231	0.000721	CcSEcCtD
Boceprevir—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.000721	CcSEcCtD
Boceprevir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000231	0.00072	CcSEcCtD
Boceprevir—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.000719	CcSEcCtD
Boceprevir—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000718	CcSEcCtD
Boceprevir—CTSL—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.00023	0.000864	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.00023	0.000864	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000229	0.00086	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000229	0.00086	CbGpPWpGaD
Boceprevir—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000713	CcSEcCtD
Boceprevir—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000227	0.000706	CcSEcCtD
Boceprevir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.000702	CcSEcCtD
Boceprevir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000225	0.000702	CcSEcCtD
Boceprevir—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000222	0.000692	CcSEcCtD
Boceprevir—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.000692	CcSEcCtD
Boceprevir—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000222	0.000691	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000222	0.000832	CbGpPWpGaD
Boceprevir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000221	0.000687	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.00022	0.000826	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.00022	0.000826	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.00022	0.000825	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	0.00022	0.000824	CbGpPWpGaD
Boceprevir—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000682	CcSEcCtD
Boceprevir—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.000681	CcSEcCtD
Boceprevir—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000218	0.000678	CcSEcCtD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.000814	CbGpPWpGaD
Boceprevir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000215	0.000808	CbGpPWpGaD
Boceprevir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000215	0.000669	CcSEcCtD
Boceprevir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.000669	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.000214	0.000803	CbGpPWpGaD
Boceprevir—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000666	CcSEcCtD
Boceprevir—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000664	CcSEcCtD
Boceprevir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.000663	CcSEcCtD
Boceprevir—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000212	0.000797	CbGpPWpGaD
Boceprevir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000211	0.000656	CcSEcCtD
Boceprevir—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.000654	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000209	0.000786	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000209	0.000786	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000209	0.000783	CbGpPWpGaD
Boceprevir—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.000649	CcSEcCtD
Boceprevir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000208	0.000647	CcSEcCtD
Boceprevir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.000647	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000205	0.00077	CbGpPWpGaD
Boceprevir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000203	0.000634	CcSEcCtD
Boceprevir—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000633	CcSEcCtD
Boceprevir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.000632	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000202	0.000759	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000201	0.000754	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000201	0.000754	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.0002	0.000752	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.0002	0.000751	CbGpPWpGaD
Boceprevir—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000624	CcSEcCtD
Boceprevir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.000622	CcSEcCtD
Boceprevir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0002	0.000622	CcSEcCtD
Boceprevir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.000617	CcSEcCtD
Boceprevir—Rash—Formoterol—chronic obstructive pulmonary disease	0.000198	0.000617	CcSEcCtD
Boceprevir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000198	0.000616	CcSEcCtD
Boceprevir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.000616	CcSEcCtD
Boceprevir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.000613	CcSEcCtD
Boceprevir—Headache—Formoterol—chronic obstructive pulmonary disease	0.000197	0.000613	CcSEcCtD
Boceprevir—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000612	CcSEcCtD
Boceprevir—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.000612	CcSEcCtD
Boceprevir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.000611	CcSEcCtD
Boceprevir—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000611	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.000196	0.000736	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000196	0.000735	CbGpPWpGaD
Boceprevir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000196	0.000609	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000195	0.000733	CbGpPWpGaD
Boceprevir—Rash—Montelukast—chronic obstructive pulmonary disease	0.000194	0.000604	CcSEcCtD
Boceprevir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000194	0.000604	CcSEcCtD
Boceprevir—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.000602	CcSEcCtD
Boceprevir—Depression—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000602	CcSEcCtD
Boceprevir—Headache—Montelukast—chronic obstructive pulmonary disease	0.000193	0.0006	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.000191	0.000716	CbGpPWpGaD
Boceprevir—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.000593	CcSEcCtD
Boceprevir—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000592	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.00019	0.000712	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.00019	0.000712	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.00019	0.000712	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TLR2—chronic obstructive pulmonary disease	0.000189	0.00071	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TLR2—chronic obstructive pulmonary disease	0.000189	0.00071	CbGpPWpGaD
Boceprevir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.000587	CcSEcCtD
Boceprevir—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.000585	CcSEcCtD
Boceprevir—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000583	CcSEcCtD
Boceprevir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.000582	CcSEcCtD
Boceprevir—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000582	CcSEcCtD
Boceprevir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.000582	CcSEcCtD
Boceprevir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000187	0.000581	CcSEcCtD
Boceprevir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.000581	CcSEcCtD
Boceprevir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.000579	CcSEcCtD
Boceprevir—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.000571	CcSEcCtD
Boceprevir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000183	0.000569	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.000182	0.000684	CbGpPWpGaD
Boceprevir—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00056	CcSEcCtD
Boceprevir—CTSV—Immune System—KL—chronic obstructive pulmonary disease	0.000178	0.000668	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KL—chronic obstructive pulmonary disease	0.000178	0.000668	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.000176	0.000662	CbGpPWpGaD
Boceprevir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.000549	CcSEcCtD
Boceprevir—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.000546	CcSEcCtD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000175	0.000655	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000174	0.000651	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000172	0.000646	CbGpPWpGaD
Boceprevir—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000532	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.00017	0.000639	CbGpPWpGaD
Boceprevir—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00017	0.000639	CbGpPWpGaD
Boceprevir—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000521	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000167	0.000625	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000166	0.000624	CbGpPWpGaD
Boceprevir—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000517	CcSEcCtD
Boceprevir—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.000512	CcSEcCtD
Boceprevir—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000506	CcSEcCtD
Boceprevir—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000503	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.000161	0.000606	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000161	0.000605	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000161	0.000603	CbGpPWpGaD
Boceprevir—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000492	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000157	0.000591	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.000157	0.00059	CbGpPWpGaD
Boceprevir—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000489	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.000157	0.00059	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TLR2—chronic obstructive pulmonary disease	0.000157	0.000589	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000156	0.000587	CbGpPWpGaD
Boceprevir—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000484	CcSEcCtD
Boceprevir—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000479	CcSEcCtD
Boceprevir—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000479	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000154	0.000576	CbGpPWpGaD
Boceprevir—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000476	CcSEcCtD
Boceprevir—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000475	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000152	0.000569	CbGpPWpGaD
Boceprevir—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000472	CcSEcCtD
Boceprevir—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000472	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.00015	0.000563	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KL—chronic obstructive pulmonary disease	0.000147	0.000553	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000147	0.000553	CbGpPWpGaD
Boceprevir—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.000453	CcSEcCtD
Boceprevir—CTSV—Immune System—CD8A—chronic obstructive pulmonary disease	0.000143	0.000538	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD8A—chronic obstructive pulmonary disease	0.000143	0.000538	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000143	0.000536	CbGpPWpGaD
Boceprevir—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000445	CcSEcCtD
Boceprevir—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000141	0.000529	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000438	CcSEcCtD
Boceprevir—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000437	CcSEcCtD
Boceprevir—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000436	CcSEcCtD
Boceprevir—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000433	CcSEcCtD
Boceprevir—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000431	CcSEcCtD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.000517	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000137	0.000516	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000137	0.000514	CbGpPWpGaD
Boceprevir—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000425	CcSEcCtD
Boceprevir—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000424	CcSEcCtD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.00051	CbGpPWpGaD
Boceprevir—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000423	CcSEcCtD
Boceprevir—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000421	CcSEcCtD
Boceprevir—CTSV—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000133	0.000501	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000133	0.000501	CbGpPWpGaD
Boceprevir—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000415	CcSEcCtD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000131	0.000493	CbGpPWpGaD
Boceprevir—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000407	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000131	0.00049	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.00013	0.000486	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TLR2—chronic obstructive pulmonary disease	0.000129	0.000485	CbGpPWpGaD
Boceprevir—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000402	CcSEcCtD
Boceprevir—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000402	CcSEcCtD
Boceprevir—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000129	0.0004	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000399	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.000479	CbGpPWpGaD
Boceprevir—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000397	CcSEcCtD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.000472	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00039	CcSEcCtD
Boceprevir—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.000465	CbGpPWpGaD
Boceprevir—Infection—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000382	CcSEcCtD
Boceprevir—CTSV—Immune System—CRP—chronic obstructive pulmonary disease	0.000122	0.000458	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CRP—chronic obstructive pulmonary disease	0.000122	0.000458	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000122	0.000457	CbGpPWpGaD
Boceprevir—Shock—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000379	CcSEcCtD
Boceprevir—CTSS—Immune System—KL—chronic obstructive pulmonary disease	0.000121	0.000456	CbGpPWpGaD
Boceprevir—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000378	CcSEcCtD
Boceprevir—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000376	CcSEcCtD
Boceprevir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000374	CcSEcCtD
Boceprevir—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000372	CcSEcCtD
Boceprevir—CTSK—Immune System—CD8A—chronic obstructive pulmonary disease	0.000119	0.000446	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TLR4—chronic obstructive pulmonary disease	0.000117	0.000439	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TLR4—chronic obstructive pulmonary disease	0.000117	0.000439	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000115	0.000432	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000351	CcSEcCtD
Boceprevir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00035	CcSEcCtD
Boceprevir—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000348	CcSEcCtD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.000419	CbGpPWpGaD
Boceprevir—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000346	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000111	0.000415	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000111	0.000415	CbGpPWpGaD
Boceprevir—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000339	CcSEcCtD
Boceprevir—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000335	CcSEcCtD
Boceprevir—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000334	CcSEcCtD
Boceprevir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000334	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000107	0.000401	CbGpPWpGaD
Boceprevir—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000332	CcSEcCtD
Boceprevir—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000332	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000106	0.000399	CbGpPWpGaD
Boceprevir—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000329	CcSEcCtD
Boceprevir—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000105	0.000394	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000103	0.000385	CbGpPWpGaD
Boceprevir—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000317	CcSEcCtD
Boceprevir—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000315	CcSEcCtD
Boceprevir—CTSK—Immune System—CRP—chronic obstructive pulmonary disease	0.000101	0.000379	CbGpPWpGaD
Boceprevir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000315	CcSEcCtD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.000376	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EGFR—chronic obstructive pulmonary disease	9.96e-05	0.000374	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EGFR—chronic obstructive pulmonary disease	9.96e-05	0.000374	CbGpPWpGaD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.88e-05	0.000371	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.87e-05	0.000371	CbGpPWpGaD
Boceprevir—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.82e-05	0.000306	CcSEcCtD
Boceprevir—CTSS—Immune System—CD8A—chronic obstructive pulmonary disease	9.79e-05	0.000367	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.78e-05	0.000367	CbGpPWpGaD
Boceprevir—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000304	CcSEcCtD
Boceprevir—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000304	CcSEcCtD
Boceprevir—CTSK—Immune System—TLR4—chronic obstructive pulmonary disease	9.69e-05	0.000364	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.64e-05	0.000362	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	9.56e-05	0.000359	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	9.56e-05	0.000359	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.27e-05	0.000348	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.14e-05	0.000343	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.11e-05	0.000284	CcSEcCtD
Boceprevir—CTSS—Immune System—ERBB3—chronic obstructive pulmonary disease	9.1e-05	0.000342	CbGpPWpGaD
Boceprevir—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.87e-05	0.000276	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.82e-05	0.000331	CbGpPWpGaD
Boceprevir—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000272	CcSEcCtD
Boceprevir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.000263	CcSEcCtD
Boceprevir—CTSS—Immune System—CRP—chronic obstructive pulmonary disease	8.32e-05	0.000312	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EGFR—chronic obstructive pulmonary disease	8.25e-05	0.00031	CbGpPWpGaD
Boceprevir—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.000255	CcSEcCtD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.11e-05	0.000304	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.02e-05	0.000301	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TLR4—chronic obstructive pulmonary disease	7.98e-05	0.000299	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	7.92e-05	0.000297	CbGpPWpGaD
Boceprevir—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.000245	CcSEcCtD
Boceprevir—Rash—Prednisone—chronic obstructive pulmonary disease	7.8e-05	0.000243	CcSEcCtD
Boceprevir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.000243	CcSEcCtD
Boceprevir—Headache—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000241	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.72e-05	0.00029	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—chronic obstructive pulmonary disease	7.65e-05	0.000287	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—chronic obstructive pulmonary disease	7.65e-05	0.000287	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1B—chronic obstructive pulmonary disease	7.61e-05	0.000286	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1B—chronic obstructive pulmonary disease	7.61e-05	0.000286	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	7.52e-05	0.000282	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	7.46e-05	0.00028	CbGpPWpGaD
Boceprevir—Nausea—Prednisone—chronic obstructive pulmonary disease	7.34e-05	0.000229	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	7.21e-05	0.000271	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.18e-05	0.000269	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.14e-05	0.000268	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.05e-05	0.000265	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	7.05e-05	0.000265	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EGFR—chronic obstructive pulmonary disease	6.79e-05	0.000255	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	6.52e-05	0.000245	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—chronic obstructive pulmonary disease	6.34e-05	0.000238	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1B—chronic obstructive pulmonary disease	6.31e-05	0.000237	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	6.11e-05	0.000229	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.93e-05	0.000223	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.85e-05	0.00022	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—chronic obstructive pulmonary disease	5.8e-05	0.000218	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—chronic obstructive pulmonary disease	5.8e-05	0.000218	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.63e-05	0.000211	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	5.63e-05	0.000211	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	5.6e-05	0.00021	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.38e-05	0.000202	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	5.23e-05	0.000196	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—chronic obstructive pulmonary disease	5.22e-05	0.000196	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—chronic obstructive pulmonary disease	5.19e-05	0.000195	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.95e-05	0.000186	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.94e-05	0.000185	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.88e-05	0.000183	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	4.81e-05	0.00018	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—chronic obstructive pulmonary disease	4.8e-05	0.00018	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.77e-05	0.000179	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.55e-05	0.000171	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.48e-05	0.000168	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.47e-05	0.000168	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—chronic obstructive pulmonary disease	4.46e-05	0.000167	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—chronic obstructive pulmonary disease	4.46e-05	0.000167	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.31e-05	0.000162	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.31e-05	0.000162	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.25e-05	0.00016	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—chronic obstructive pulmonary disease	3.96e-05	0.000148	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.87e-05	0.000145	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.73e-05	0.00014	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—chronic obstructive pulmonary disease	3.69e-05	0.000139	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	3.63e-05	0.000136	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.55e-05	0.000133	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.49e-05	0.000131	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.47e-05	0.00013	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.37e-05	0.000127	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—chronic obstructive pulmonary disease	3.04e-05	0.000114	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.01e-05	0.000113	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.93e-05	0.00011	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.89e-05	0.000109	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.77e-05	0.000104	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.71e-05	0.000102	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.68e-05	0.000101	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.63e-05	9.85e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.6e-05	9.74e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.58e-05	9.69e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.37e-05	8.89e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.3e-05	8.62e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.28e-05	8.54e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.23e-05	8.38e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.18e-05	8.19e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.08e-05	7.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.98e-05	7.43e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.96e-05	7.35e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.82e-05	6.83e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.79e-05	6.73e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.79e-05	6.71e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.74e-05	6.51e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.67e-05	6.28e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	6.18e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	5.95e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.37e-05	5.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.35e-05	5.08e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-05	4.74e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.22e-05	4.58e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.21e-05	4.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	4.49e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.1e-05	4.13e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.08e-05	4.04e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.03e-05	3.87e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	3.81e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.46e-06	3.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.34e-06	3.13e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	8.13e-06	3.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.78e-06	2.92e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.77e-06	2.92e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.37e-06	2.77e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.01e-06	1.88e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.79e-06	1.8e-05	CbGpPWpGaD
